What is the appropriate workup for painless hematuria?

Workup for Painless Hematuria

All patients with painless hematuria require a thorough history, physical examination, urinalysis, and serologic testing, followed by risk-stratified imaging and cystoscopy to exclude malignancy. 1

Initial Clinical Assessment

History and Physical Examination

Before any imaging, obtain:

• Detailed smoking history (most critical risk factor for malignancy) 1
• Occupational exposures to chemicals or carcinogens 1
• History of pelvic irradiation, chronic UTIs, or chemotherapy exposure 1
• Irritative voiding symptoms and prior urologic disease 1
• Analgesic abuse history and presence of chronic indwelling foreign bodies 1
• Pelvic examination in women and rectal examination in men 1

Laboratory Workup

• Properly collected urinalysis with microscopy (≥3 RBCs/HPF defines microhematuria) 1
• Urine culture if infection suspected (obtain before antibiotics) 1
• Serologic testing including creatinine to assess for renal parenchymal disease 1

Risk Stratification

Gross Hematuria

All patients with gross hematuria require full urologic workup regardless of age or risk factors due to 30-40% malignancy risk 1

Microhematuria Risk Factors

High-risk patients (requiring complete evaluation) have:

• Age >35 years 1
• Male gender 1
• Smoking history 1
• Occupational chemical exposure 1
• History of gross hematuria 1
• Chronic UTIs or urologic disease 1
• Pelvic irradiation or chemotherapy 1

Patients Who May NOT Need Full Workup

Defer complete imaging in microhematuria patients with identified benign causes and no risk factors:

• Recent vigorous exercise 1
• Active menstruation 1
• Confirmed UTI (re-evaluate after treatment) 1
• Recent urologic procedure or trauma 1

Important caveat: Anticoagulation does NOT alter the need for evaluation 1

Imaging Evaluation

First-Line Imaging by Risk Category

High-Risk Patients (including all gross hematuria):

• CT urography (CTU) is the preferred imaging modality 1
• CTU must include unenhanced phase, nephrographic phase, and excretory phase (≥5 minutes post-contrast) 1
• Use thin-slice acquisition with maximum intensity projection or 3D volume rendering 1

Low-Risk Patients (<35 years, no risk factors, microhematuria):

• Ultrasound is appropriate initial imaging to minimize radiation exposure 1, 2

Special Populations:

• Pregnant patients: MR urography (MRU) without contrast or ultrasound 1
• Renal impairment: MRU with heavily T2-weighted sequences (no contrast needed) 1
• Pediatric patients: Ultrasound or MRU 1

MR Urography Protocol (when indicated)

• Heavily T2-weighted imaging for intrinsic urine signal 1
• If contrast used: corticomedullary, nephrographic, and excretory phases 1
• Thin-slice acquisition with multiplanar imaging 1

Cystoscopy

Cystoscopy is mandatory in addition to imaging for most patients with hematuria 1

Indications for Cystoscopy:

• All patients with gross hematuria 1
• All high-risk patients with microhematuria 1
• Patients with irritative voiding symptoms 1
• Suspected bladder pathology (BPH, interstitial cystitis) 1

Rationale: Cystoscopy remains the gold standard for detecting lower urinary tract/bladder urothelial tumors that may be missed on imaging 2

Special Considerations

Renal Parenchymal Disease

If urinalysis shows:

• Dysmorphic RBCs, cellular casts, or proteinuria 3
• Elevated creatinine or hypertension 3

Concurrent nephrology referral is required, but this does NOT preclude urologic evaluation 1

Follow-Up After Negative Evaluation

• Most patients with negative risk-stratified evaluation do not require ongoing urologic monitoring 4
• Shared decision-making regarding repeat UA in patients with multiple risk factors or heavy smoking history 4
• Repeat evaluation is warranted if new gross hematuria, worsening symptoms, or increased degree of microhematuria develops 4

Common Pitfalls to Avoid

• Do not skip workup in anticoagulated patients - anticoagulation does not explain hematuria 1
• Do not use standard CT abdomen/pelvis instead of CTU - must include precontrast and excretory phases 1
• Do not omit cystoscopy when imaging is negative in high-risk patients 1
• Do not assume UTI explains hematuria - confirm with culture and re-evaluate after treatment 1
• Do not delay evaluation in gross hematuria regardless of patient age or perceived benign causes 1